| Literature DB >> 21837493 |
S Krege1.
Abstract
The management of testicular cancer has already been standardized to the greatest extent by consistent performance of clinical trials. While the current aim is to reduce the therapy for early stage disease without jeopardizing the high cure rates, for patients in advanced stages the goal is to achieve further improvement of survival rates. This overview presents new aspects of organ-preserving primary tumor resection, prognostic factors in seminoma, secondary malignancies, high-dose therapy, residual tumor resection, aftercare, and PET/CT.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21837493 DOI： 10.1007/s00120-011-2671-y
Source DB: PubMed Journal: Urologe A ISSN： 0340-2592 Impact factor: 0.639